SAM
TEVA icon

Smartleaf Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Smartleaf Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$485K Hold
14,573
– – 0.02% 561
2026
Q1 		$413K Buy
14,573
+2,313
+19% +$74.4K 0.01% 577
2025
Q4 		$384K Buy
12,260
+1,466
+14% +$36.1K 0.01% 587
2025
Q3 		$207K Buy
10,794
+624
+6% +$11K 0.01% 717
2025
Q2 		$170K Sell
10,170
-1,058
-9% -$17.1K 0.02% 627
2025
Q1 		$169K Sell
11,228
-2,972
-21% -$53.1K 0.02% 625
2024
Q4 		$317K Buy
14,200
+2,660
+23% +$48.4K 0.03% 424
2024
Q3 		$201K Buy
11,540
+5,148
+81% +$90.1K 0.02% 493
2024
Q2 		$104K Buy
6,392
+2,134
+50% +$32.9K 0.02% 566
2024
Q1 		$61.4K Buy
+4,258
New +$53.7K 0.01% 633

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Smartleaf Asset Management's TEVA Position: Q2 2026 in Review

Smartleaf Asset Management held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 14,573 shares worth $485K. The position accounts for 0.02% of the portfolio, ranked #561.

Smartleaf Asset Management first reported a position in TEVA in Q1 2024 and has held it in 10 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Smartleaf Asset Management held 14,573 shares of Teva Pharmaceuticals worth $485K as of Q2 2026.
  • Smartleaf Asset Management left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up 0.02% of Smartleaf Asset Management's portfolio in Q2 2026, its #561 holding.
  • Smartleaf Asset Management first reported a position in Teva Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.